News Author: Lucas Franki Publish date: May 26, 2021
Plus, brains that can type and geologists who conduct kidney research.
News Author: Lucas Franki Publish date: May 20, 2021
Plus, a product that puts cleanliness next to snail-iness.
News Author: Lucas Franki Publish date: May 13, 2021
Plus, a cheaper, fuzzier way to test for coronavirus.
News Author: Lucas Franki Publish date: April 28, 2021
Plus, loneliness as a health issue and high-flying, high-technology shirts.
News Author: Lucas Franki Publish date: April 22, 2021
Plus, counting public restroom aerosols and raising less intelligent mice.
News Author: Lucas Franki Publish date: April 15, 2021
Plus, the twin joys of superfetation and Lady Liberty’s contribution to COVID-19 misinformation.
News Author: Lucas Franki Publish date: April 8, 2021
Plus, Star Trek retractions and full placebo disclosure.
News Author: Lucas Franki Publish date: March 24, 2021
Since 2017, pediatrics has offered more slots every year, rising from 2,738 in 2017 to 2,901 in 2021, an overall growth rate of just under 6%.
News Author: Lucas Franki Publish date: March 23, 2021
Available dermatology PGY-2 slots fell by 0.2% from 478 in 2020 to 477 in 2021, but 471 slots were filled in 2021, 2 more than last year.
News Author: Lucas Franki Publish date: July 7, 2020
The first injectable cellulite treatment receives regulatory approval.
News Author: Lucas Franki Publish date: June 17, 2020
The approval marks secukinumab’s fourth approved indication, following moderate to severe plaque psoriasis, psoriatic arthritis, and ankylosing spo...
News Author: Lucas Franki Publish date: June 15, 2020
Second FDA-approved therapy for neuromyelitis optica spectrum disorder offers patients additional treatment option.
News Author: Lucas Franki Publish date: June 11, 2020
This phase 3 trial demonstrates that the investigational drug baloxavir marboxil is noninferior to oseltamivir, a drug for alleviating flu symptoms...
News Author: Lucas Franki Publish date: June 5, 2020
Recarbrio was previously approved by the FDA to treat patients with complicated urinary tract infections and complicated intra-abdominal infections...
News Author: Lucas Franki Publish date: June 1, 2020
The approval was supported by results from the phase 3 RELAY trial.
